Workflow
Johnson & Johnson Stock Brushes Off Beat-and-Raise
强生强生(US:JNJ) Schaeffers Investment Research·2025-10-14 22:05

Johnson & Johnson (NYSE:JNJ) stock is down 1.2% to trade at 188.54atlastglance,brushingoffanearningsandrevenuebeatforthethirdquarter.The pharmacompany alsoannounceditwillspinoffitsorthopedicsbusiness,raiseditsfull−yearforecast,andissuedadividendforthefiscalfourthquarter.Inresponse,UBSincreaseditspriceobjectiveto188.54 at last glance, brushing off an earnings and revenue beat for the third quarter. The pharma company also announced it will spin off its orthopedics business, raised its full-year forecast, and issued a dividend for the fiscal fourth quarter. In response, UBS increased its price objective to 214 from 190.SharesaretakingabreatherfromtheirOct.9,recordhighof190.Shares are taking a breather from their Oct. 9, record high of 192.10, which followed a bounce off long-term support at the 40-day movin ...